A1AT levels are upregulated in the renal tissue of adenine-induced chronic renal failure model [34] and in vivo administration of clinical grade A1AT improves renal function, decreases acute tubular necrosis and ameliorates acute kidney injury following experimental kidney ischemia reperfusion damage [35]. The gene discussed is SERPINA1; the disease is chronic kidney disease.